跳至主要内容
临床试验/NCT04787510
NCT04787510已完成不适用

COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

University Hospital, Ioannina1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年12月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
EFFECT OF COVID-19 DISEASE IN CLOTTING FACTORS

研究概览

简要总结

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

详细描述

Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection.

Association between clotting factors levels and disease severity,morbidity and mortality in these patients.

Effect of anticoagulant therapy in the clotting factors' levels in these patients

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SINGED INFORMED CONSENT FORM
  • POSITIVE PCR TEST FOR SARS-COV2 INFECTION
  • FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT

排除标准

  • DENIAL TO PROVIDE INFORMED CONSENT FORM
  • HISTORY OF MALIGNANCY
  • PRIOR USE OF ANTICOAGULANT THERAPY
  • PRIOR USE OF STEROIDS LONGER THAN 14 DAYS
  • LACTATION-PREGNANCY

结局指标

主要结局

EFFECT OF COVID-19 DISEASE IN CLOTTING FACTORS

时间窗: 6 MONTHS

leves of cloting factors before and after treatment with LMWH

次要结局

未报告次要终点

研究者

发起方
University Hospital, Ioannina
申办方类型
Other
责任方
Principal Investigator
主要研究者

Liontos Angelos

CONSULTANT OF INTERNAL MEDICINE

University Hospital, Ioannina

研究点 (1)

Loading locations...

相似试验